Skip to main content
logo
NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
15.69
-0.36 (-2.24%)
At close: Aug 6, 2026, 4:00 PM EDT
15.70
+0.01 (0.05%)
After-hours: Aug 6, 2026, 5:17 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Tumor Treating Fields (TTFields)
655.35M605.22M509.34M537.84M535.03M
Total
655.35M605.22M509.34M537.84M535.03M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
385.63M391.80M349.74M406.89M353.11M
Germany
79.41M65.26M60.21M46.12M93.94M
France
76.19M55.73M11.74M--
Japan
37.79M32.57M31.67M32.78M34.64M
Other International Markets
56.90M42.47M32.76M30.71M30.58M
Greater China
19.44M17.39M23.22M21.33M22.77M
Total
655.35M605.22M509.34M537.84M535.03M